PR Newswire Asia's news > Medical/Pharmaceuticals

 |   Title only   |   Print    Next page > 
     
Kelun-Biotech Receives a Clinical Trial Notice for Its First Dual-payload ADC SKB565
CHENGDU, China , July 27, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) today announced that it has received ...
2026-07-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Articura Launches a New Chapter for Sovereign Healthcare AI in Indonesia
Hospitals, clinics, academia and industry join a collaborative ecosystem designed to advance trusted, nationally grounded healthcare AI ...
2026-07-27T    Health Care/Hospital   Medical/Pharmaceuticals 
Ascletis Announces Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, Demonstrated Superior Weight Loss in a Diet-Induced Obese Mouse Model
-ASC37 demonstrated statistically significant 88% greater relative body weight reduction compared to tirzepatide in the diet-induced obese (DIO) mouse model. -Both ASC37 once-monthly subcutaneous (SQ) ...
2026-07-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Bambusa Therapeutics Reports Potentially Transformative Preliminary Proof-of-Concept Results for BBT001 in Atopic Dermatitis, Reinforcing Its Best-in-Disease Potential
BBT001 delivered highly statistically significant and clinically meaningful improvement in EASI beginning at Week 1, with responses continuing to improve over time ...
2026-07-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Harbour BioMed and Sinopharm Enter Strategic Collaboration to Establish Innovation R&D Consortium
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , July 27, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development ...
2026-07-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Home Control's Orbiva Signs Strategic MOU with Indonesia's Articura to Advance Localized Healthcare AI and AIoT Digital Health Ecosystem
HONG KONG , July 27, 2026 /PRNewswire/ -- Home Control International Limited  ("Home Control" or the "Company", together with its subsidiaries, the "Group"; Stock ...
2026-07-27T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
IHH Healthcare Expands 'IHH Catalyst' to North Asia to Accelerate Clinical Adoption of Healthcare Innovation
Building on the success of its inaugural programme in India, IHH Healthcare is launching IHH Catalyst | North Asia Edition to help startups in Hong Kong, Chinese Mainland and neighbouring markets turn ...
2026-07-27T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Seaweed extract shown to relieve prostate symptoms
In a breakthrough clinical trial undertaken by Australian biotechnology company Marinova, a unique seaweed extract has been shown to relieve the symptoms of benign prostatic hyperplasia (BPH). ...
2026-07-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
International Self-Care Day: Dimora Medical Highlights Wound Care as an Essential Part of Everyday Self-Care
NEW YORK , July 25, 2026 /PRNewswire/ -- As International Self-Care Day draws attention to the importance of maintaining health around the clock, the concept of 24/7 self-care continues to gain momentum ...
2026-07-25T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Nova Biomedical Advances Integrated Cell Line Development Workflows: NanoCellect products are now part of Nova Biomedical
WALTHAM, Mass. , July 24, 2026 /PRNewswire/ -- Nova Biomedical today announced a transaction involving certain assets of NanoCellect, a provider of microfluidic cell sorting technology. ...
2026-07-24T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
  Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.